Target expands protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand for ...

GLP-1 side effects like constipation and muscle mass loss can lead to uncomfortable pelvic floor symptoms like bladder leakage and painful sex.

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...

The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are ...

A failed clinical study has not closed the door on using GLP-1 drugs to treat vascular dementia. Researchers say the science ...

The WHO has officially recommended GLP-1 drugs, such as semaglutide, for treating obesity in adults at high risk of ...

Current GLP-1 weight-loss meds need to be taken as injections, but new trial results suggest a GLP-1 in pill form could be near In an 18-month clinical trial, people with obesity and diabetes lost ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

Telehealth is making it easier for people to access GLP-1 medications, but insurance coverage and understanding those rules are still big hurdles for many patients in 2025. New tech and personalized ...

Women who stop taking a GLP-1 weight loss/diabetes medication just prior to a pregnancy appear to be at higher odds for excess weight gain and complications while pregnant, new research shows. As the ...

Kristen Fischer has written for numerous health publications, hospitals, and medical companies, and is a member of the Association of Health Care Journalists. Nick Blackmer is a librarian, ...